Allurion Technologies, Inc.
Symbol: ALUR (NYSE)
Company Description:
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
- Today's Open: $2.9
- Today's High: $3.07
- Today's Low: $2.915
- Today's Volume: 73.38K
- Yesterday Close: $2.93
- Yesterday High: $3.215
- Yesterday Low: $2.92
- Yesterday Volume: 119.88K
- Last Min Volume: 1
- Last Min High: $3.01
- Last Min Low: $3.01
- Last Min VWAP: $3.01
- Name: Allurion Technologies, Inc.
- Website: https://www.allurion.com
- Listed Date: 2023-08-02
- Location: NATICK, MA
- Market Status: Active
- CIK Number: 0001964979
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $21.85M
- Round Lot: 100
- Outstanding Shares: 7.46M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-06-18 | S-8 | View |
2025-05-21 | 4 | View |
2025-05-20 | 424B3 | View |
2025-05-20 | 424B3 | View |
2025-05-15 | 10-Q | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-14 | 8-K | View |
2025-05-09 | EFFECT | View |
2025-05-07 | CORRESP | View |
2025-05-06 | UPLOAD | View |
2025-04-30 | S-3 | View |
2025-04-18 | 424B3 | View |
2025-04-18 | 424B3 | View |
2025-04-17 | 4 | View |
2025-04-17 | SCHEDULE 13D/A | View |
2025-04-17 | 8-K | View |
2025-04-11 | 424B3 | View |
2025-04-11 | 424B3 | View |
2025-04-10 | 8-K | View |
2025-04-03 | DEFA14A | View |